The serum levels of IL-6 in patients with colorectal cancer (CRC) are correlated with the malignant tumor grade, and high IL-6 levels (≥10 pg/mL) are an independent indicator of poor prognosis [58]. This evidence concerns the gene IL6 and cancer.